Your monthly AI in biotech digest – September

Topic:

Top market ‘AI in biotech’ stories

Here’s your latest installment of our selection of AI in biotech news.

In just 3–4 minutes, catch up on the innovations reshaping drug discovery and biomedical research. We are delivering fresh insights to your inbox on the second Tuesday of each month, so you can stay informed and inspired. Happy reading!

In today’s edition:

  1. 🩺 AI-powered stethoscope outperforms doctors
  2. 💊 Old drug, new purpose: AI finds COPD treatment
  3. 🧪 Chai’s generative model hits 1-in-6 design success
  4. 👅 Graphene “tongue” tastes and learns like a human
The AI stethoscope: 200-year-old tool, reinvented

Researchers from Imperial College London and the NHS have created a card-sized AI stethoscope that diagnoses heart failure, valve disease, and atrial fibrillation in just 15 seconds.

In a UK trial with 12,000 patients, the device outperformed traditional methods:

  • 2x more accurate in diagnosing heart failure,
  • 3x better at detecting atrial fibrillation,
  • nearly 2x more effective for valve disease.

A simple form factor with potentially life-saving implications!

source: The Guardian

 

AI finds hidden potential in old drugs

A collaboration between Hudson Institute and Monash University used AI to repurpose pirfenidone, a drug for lung fibrosis, as a potential treatment for COPD.
The AI-driven insight was validated in preclinical models, showing reduced inflammation and viral replication—without compromising immunity, unlike steroids.

source: Hudson Institute

 

AI breaks the 1-in-1000 barrier in drug design

Chai Discovery, supported by OpenAI, just raised $70M to scale its molecular design platform. Their new model, Chai‑2, achieves a 1-in-6 success rate in generating functional proteins—vs. 1-in-1000 with traditional approaches.

source: BusinessWire

 

The learning artificial tongue is here

Scientists have developed a graphene-based “tongue” that can taste, store flavor data, and learn over time—no external processor required.
It senses ionic taste signatures and adapts its accuracy after each exposure.

Test results:

  • 72–88% accuracy on basic tastes (sweet, sour, salty, bitter)
  • 96% on complex mixtures like coffee or cola

What makes it notable:

This is a breakthrough in neuromorphic sensing, with applications in diagnostics, food safety, and taste disorder support.

source: livescience.com

 

Don’t miss next month’s AI insights

You might be also interested in:

Can AI Stop the Cost Spiral in Drug Discovery? Summary of Our Expert Talk at BioTech X 2025
Your monthly AI in biotech digest – October
Abstract visualization of AI-driven analysis of patient data, representing precision medicine and responder identification.
Precision Trials: Using AI to Identify Responders
Poster: Safer pHLA-Targeted Immunotherapies Through AI and Computational Immunology

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!